national jewish medical

Gregory Downey, M.D., of National Jewish Health, honored for sci...

EurekAlert! - Medicine and Health  Sun, 05/16/2010 - 22:00

(National Jewish Medical and Research Center) Gregory Downey, M.D., received the 2010 Recognition Award for Scientific Accomplishments at the American Thoracic Society's International Conference on Monday, May 17.

Dr. Downey, Executive Vice President of Academic Affairs and Professor of Medicine, Pediatrics and Immunology at National Jewish Health, has over 190 publications to his credit.

He has been cited by other authors more than 5,000 times, putting him in the top one percent of cited authors.


 

Long-acting beta-agonists most effective step-up therapy for chi...

EurekAlert! - Medicine and Health  Mon, 03/01/2010 - 23:00

(National Jewish Medical and Research Center) For children whose asthma is not well controlled and on low doses of inhaled corticosteroids, a long-acting beta-agonist (LABA) may be the most effective of three possible step-up treatments.

National Jewish clinician-scientists Stanley Szefler, Joseph Spahn, Ronina Covar, Gary Larsen and Lynn Taussig, and colleagues in the NIH-funded Childhood Asthma Research and Education Network published their findings March 2, 2010, online in the New England Journal of Medicine.


 

National Jewish faculty present research findings at AAAAI

EurekAlert! - Infectious and Emerging Diseases  Mon, 03/01/2010 - 23:00

(National Jewish Medical and Research Center) Dozens of National Jewish Health faculty presented their latest research findings at the annual meeting of the American Academy of Allergy Asthma & Immunology in New Orleans Feb. 27-March 2, 2010.

Below are several noteworthy presentations.


 

NHLBI awards $11 million for molecular roadmap to chronic lung d...

EurekAlert! - Medicine and Health  Tue, 10/06/2009 - 22:00

(National Jewish Medical and Research Center) Researchers at five medical centers have been awarded an $11 million grant from the National Heart Lung and Blood Institute to delve deeply into the biology of two fatal lung diseases for which there are few therapeutic options.

The Lung Genomics Research Consortium will use advanced genetic and molecular tools to characterize and better understand chronic obstructive pulmonary disease and pulmonary fibrosis, then share its discoveries with researchers in a Web-accessible data warehouse.